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ABSTRACT  
Purpose  
  Opioid therapy is commonly prescribed to combat surgical pain in hospitals across the United 
States and is associated with many negative side effects including dependence and nausea. The purpose 
of this study was to retrospectively examine the effects of scheduling acetaminophen and 
methocarbamol administration postoperatively throughout the cardiac surgery patients’ hospital stay. 
Through retrospective chart reviews, the aims of postoperative opioid use, postoperative opioid use 
according to hospital length of stay, antiemetic use, and opioid prescription at discharge were compared 
between two cohorts: a scheduled acetaminophen and methocarbamol cohort and a non-scheduled 
cohort.  
Setting & Population   
  The study takes place at The University of Kentucky’s Cardiovascular Intensive Care Unit and 
telemetry floors at Albert B. Chandler Medical Center in Lexington, Kentucky. Coronary artery bypass 
graft (CABG) and valve replacement surgical patients were the target population. A total of 77 patients 
were included in this retrospective study divided into two cohorts. The scheduled cohort had 27 patients 
and the non-scheduled cohort had 50. The mean age for scheduled cohort was 60.8 while nonscheduled 
was 59.5 while 97.4 percent of the participants were white.   
Results  
  The scheduled cohort had a sum of opioids mean of 23.5 and the non-scheduled cohort had a 
sum of opioids mean of 25.5. There was no significant difference in means between the two cohorts (p= 
.47). There was no significant difference between the two cohorts of hospital length of stay less than 
one week and greater than one week (p=.07, .533 respectively); however, less than one week, the p 
value was lower (p=.07) and when examining the mean scores of scheduled less than one week with a 
mean of 15.6, and non- scheduled less than one week with a mean of 22.1; clinical relevance can be 
argued. No significant association existed (p= .753) between those discharged home on opioids between 
the two cohorts; however, clinical relevance is argued. No significant difference between the two 
cohorts and antiemetic use (p= .107).   
Conclusion  
  Limitations to the study included the setting being a single center study with a minimally diverse 
patient population and strict inclusion/ exclusion criteria that impeded sample size. When developing 
future studies, consideration should be given to hospital LOS due to this study’s clinically relevant 
findings. Future research is needed for cardiac surgery patients and ways to mitigate those discharged 
home on opioids. Future studies could alter the “scheduling” definition to include patients receiving 
 acetaminophen and methocarbamol greater than or equal to four times in a 24-hour period (+ or – four 
hours). Future research could also include more in-depth communication among all disciplines involved 
including ways to mitigate the technological errors encountered in this study. Dissemination of the 
surgical guidelines published by the American Pain Society (2016) and The Enhanced Recovery After 
Surgery Society (2019) that promote scheduling acetaminophen postoperatively could occur in an 
educational in-person session to the cardiac surgery service line and serve as beneficial along with this 
study’s clinically relevant findings. Notable ethical concerns include the primary investigator’s 
employment as a nurse within UK’s Cardiovascular Intensive Care Unit. This study contributes to the 
knowledge of the effects related to scheduling postoperative acetaminophen and methocarbamol 
among cardiac surgery patients and has the potential to offer insight on future study designs. 
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BACKGROUND and SIGNIFICANCE  
Opioid therapy is commonly prescribed to combat surgical pain in hospitals across the United  
States and is associated with many negative side effects including dependence, constipation, and nausea  
(Chisolm-Burns, et al., 2016). High rates of post-surgical opioid addiction span the United States; 
(Compton, Mena Sethi, & Sigman, 2017) meanwhile, Kentucky is the fifth leading state in the nation’s 
opioid epidemic with a 40 percent increase in drug overdose rates in the last five years (Office of Drug 
Control Policy, 2018). One in eight cardiac surgery patients are at risk for opioid dependence and 
patients who begin taking opioids for the first time, known medically as opioid naïve, after a heart 
operation are at risk for chronic use (The Society of Thoracic Surgeons, 2019). Opioid dependence is not 
the only side effect warranting attention. Nausea has been reported to occur in 25 percent of patients 
treated with opioids (Kane-Gill et al., 2014; American Pain Society, 2016).  
Incision-related and intraoperative bone and tissue manipulation are just some of the many 
common causes of postoperative pain experienced by surgical patients (Mueller et at., 2000). Cardiac 
surgery patients may experience previously stated causes of surgical pain, in addition to chest tube 
associated pain (Mueller et al., 2000). Chest tubes are placed in cardiac surgery patients to drain 
intrathoracic fluids caused from surgery and to facilitate lung expansion; however, manipulation and 
movement of these chest tubes during the postoperative recovery process can produce significant pain 
for the patient (Mueller et al., 2000). Chest, upper-back and shoulder muscle tightness are common 
sources of cardiac surgery post-operative pain as well (The Society of Thoracic Surgeons, 2009).     
Opioid therapy is the first line treatment therapy for pain among cardiac surgery patients in the 
cardiovascular intensive care unit at the University of Kentucky Chandler Medical Center. Adjunctive 
pain management therapy is often recognized as an alternative way to reduce opioid use 
postoperatively. Scheduling acetaminophen and methocarbamol is intermittently used in my unit among 
cardiac surgery patients but is not standard therapy. Two surgical guidelines suggest clinicians provide 
adults with acetaminophen in conjunction with opioids (American Pain Society’s Clinical Practice  
Guideline on Management of Postoperative Pain, 2016; Enhanced Recovery After Surgery Society’s 
Guidelines for Care in Perioperative Cardiac Surgery, 2019). The combination of opioids and 
acetaminophen is associated with less postoperative pain and/or opioid use compared to opioids alone 
(American Pain Society, 2016). Both surgical guidelines previously mentioned also recommend 
scheduling acetaminophen with postoperative CABG patients (American Pain Society, 2016; Engelman et 
al. 2019). Along with acetaminophen use, adjunctive methocarbamol, a skeletal muscle relaxant, is 
associated with diminished postoperative pain and opioid consumption (Hidalgo & Pusic, 2005; Looke & 
Kluth, 2013).  
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PURPOSE STATEMENT  
The purpose of this study was to examine effects of scheduled acetaminophen and 
methocarbamol administration on postoperative cardiac surgery patients during their entire hospital 
stay. This was completed through retrospective chart review comparisons between a historical control, 
referred to as non-scheduled cohort, and the scheduled acetaminophen/ methocarbamol intervention 
cohort (referred to as the scheduled cohort).The following aims and associated objectives guided this 
research:   
Aim One: Does scheduling acetaminophen and methocarbamol postoperatively impact the average 
postoperative opioid use among cohorts?  
• Objective One- Postoperative opioid use per patient as evidenced by total number of 
occurrences of opioid administrations (oxycodone, hydrocodone, morphine and 
hydromorphone) on patients' medication administration records (MARs) throughout entire 
hospital length of stay.  
Aim Two: Does scheduling acetaminophen and methocarbamol postoperatively impact the average 
postoperative opioid use among cohorts when examining patients with hospital length of stay less 
than one week and greater than one week?  
• Objective Two- Postoperative opioid use per patient as evidenced by total number of 
occurrences of opioid administrations on patients’ MARs for patients with hospital length of 
stay (LOS) less than one week and more than one week throughout hospital stay. Aim 
Three: Does scheduling acetaminophen and methocarbamol postoperatively impact the 
average amount of those discharged home on opioids among cohorts?  
• Objective Three- Side effect of potential dependence as evidenced by number of opioid 
prescriptions at discharge.  
Aim Four: Does scheduling acetaminophen and methocarbamol postoperatively impact the average 
postoperative antiemetic use among cohorts?  
• Objective Four- Side effect of postoperative nausea as evidenced by total number of 
occurrences of ondansetron and promethazine administrations on MARs throughout 
hospital stay.  
  
THEORETICAL and CONCEPTUAL FRAMEWORK  
My DNP project was grounded in Kolcaba’s Comfort Theory (2002) which is patient-centered and 
central to nursing values. Kolcaba identifies three types of comfort:   
1. Relief (a state in which comfort needs are met)  
2. Ease (the state of calm or contentment)  
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3. Transcendence (the state in which one overcomes and rises above problems or pain)  
(Kolcaba, 2002).  
Kolcaba’s Comfort Theory states when patients are most comfortable, they engage more in 
health-seeking behaviors that include internal and external behaviors. In turn, when patients engage in 
health-seeking behaviors more, the institution benefits in such areas as reduced cost of care, length of 
stay, increased patient satisfaction, enhanced financial stability, and more positive publicity (Kolcaba, 
2002). Kolcaba’s Comfort Theory can be applied to this DNP final project through the conceptual 
framework illustrated in appendix one. This conceptual framework among cardiac surgical patients 
supports an individualized patient approach and highlights the optimal types of comfort they experience 
while recovering postoperatively via the scheduling of acetaminophen and methocarbamol. First, 
patients experience a state of pain relief after scheduled acetaminophen and methocarbamol is 
administered. Next, patients experience the ease, or calm, of the new postoperative pain management 
therapy working to minimize pain and possibly reduce postoperative opioid use and associated side 
effects as they progress through their hospital stay. Finally, transcendence of the patient occurs after 
discharge when they leave the hospital and overcome the risk of experiencing postoperative opioid 
associated side effects.    
  
LITERATURE REVIEW  
A literature review was done to synthesize the existing published, peer-reviewed research 
involving postoperative opioid-associated side effects of dependence and nausea to provide support for 
scheduling acetaminophen and/or methocarbamol postoperatively. The following searches produced 17 
studies related to opioid use, acetaminophen, and methocarbamol use in the surgical population: 
postoperative cardiac surgery/ surgical patients, postoperative opioid use, acetaminophen and 
methocarbamol postoperative opioid use, postoperative opioid complications.  
Opioid therapy is commonly prescribed to combat surgical pain in hospitals. High rates of 
postsurgical opioid addiction span the United States; (Compton et al., 2017) meanwhile, Kentucky is the 
fifth leading state in the nation’s opioid epidemic with a 40 percent increase in overdose rates in the last 
five years (Office of Drug Control Policy, 2018). Opioid exposure before surgery is a known risk factor for 
abuse postoperatively (Compton et al., 2017; Hah, Bateman, Ratliff, Curtin, & Sun, 2017) but what about 
those with no history of opioid exposure? Multiple retrospective cohort studies have shown 
postoperative opioid use among opioid naïve surgical patients to be associated with opioid dependence 
(Brescia et al., 2019; Sun, Darnell, Baker, & Mackey, 2016; Brummett et al., 2017; Clarke et al., 2014; 
Calcaterra et al., 2015; Mechcatie, 2018) suggesting all those exposed to opioids postoperatively are at 
risk for dependence including those opioid naïve and tolerant.  
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When reviewing opioid naïve postoperative patients, Brescia et al. (2019)’s study highlighted 
one in eight cardiac (12.5 percent) opioid naïve surgery patients are at risk for opioid dependence while 
Sun et al., (2016) concluded a variety of surgical procedures are affiliated with opioid dependence 
among opioid naïve patients including total knee arthroplasty, open and laparoscopic cholecystectomy, 
open appendectomy, cesarean delivery, functional endoscopic sinus surgery, cataract surgery, and 
transurethral prostate resection.  Brummett et al. (2017) discovered among opioid naïve major and 
minor surgical patients that 5.9- 6.5 percent developed new, persistent opioid use 90-180 days after the 
surgical procedure. One Canadian retrospective cohort study found among opioid naïve patients who 
had major elective surgery including cardiac procedures- 49 percent were discharged home with an 
opioid prescription while 3.1 percent continued to receive opioids for more than 90 days postoperatively 
(Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014). Narrative reviews infer opioids administered during and 
after surgery may precipitate opioid dependence despite opioid naïve or tolerant status (Hah, Bateman, 
Ratliff, Curtin, & Sun, 2017; Clark & Schumacher, 2017).  
 One retrospective cohort study at a single institution examined opioid dependence among 
CABG patients (Hirjii, et al., 2019). The study defined postoperative opioid dependence as having an 
opioid prescription 90 days after discharge including those participants that were preoperatively opioid 
naïve and opioid exposed (Hirjii, et al., 2019). The study concluded 3.2 percent of opioid naïve and 21.7 
percent of opioid exposed patients were opioid dependent 90 days after discharge while 72 percent of 
opioid naïve postoperative CABG patients were discharged home with opioids (Hirjii, et al., 2019)  
Multiple studies associated postoperative opioid dependence with opioid prescription at  
discharge (Hirijii et al., 2019; Clarke et al., 2014; Brummett et al., 2017). In fact, two retrospective 
cohorts concluded long duration of postoperative opioid prescriptions as a greater indicator of abuse/ 
dependence than increased dosage rates (Mechcatie, 2018; Shah, Hayes & Martin, 2017).  
According to the literature, postoperative opioid side effects do not just involve dependence.  
Many sources cite constipation, respiratory depression, and nausea as some of the most commonly 
experienced opioid-related side effects (Kane-Gill et al., 2014; Swegle & Logemann, 2006). Nausea has 
been reported to occur in 25 percent of patients treated with opioids while constipation is the most 
common adverse effect (Kane-Gill et al., 2014; American Pain Society, 2016).   
The opioid associated adverse drug events named above (OAADE), also known as opioid-related 
side effects, do not come without consequence. The presence of OAADEs was associated with a 29 
percent increase in hospitalization costs, and a 55 percent longer length of stay (Urman et al., 2019).  
OAADEs increased hospital length of stay by as much as 4 days in one systematic review (Kane-Gill et al., 
2014). Few prospective studies exist relating cost and consequence of opioid associated adverse drug 
events among postoperative patients in general, as well as postoperative cardiac patients.   
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Postoperative opioid dependence and the associated side effect of nausea are surgical 
complications deserving attention and a directed effort at mitigating exposure among opioid naïve and 
tolerant patients postoperatively. Postoperative opioids should be kept to a minimum or avoided 
entirely (Enhanced Recovery After Surgery Society and European Society of Thoracic Surgeons, 2019). 
More prospective random control trials and cohort studies are needed examining the cardiac surgery 
patient population and associated their specific opioid-related side effects.  
Adjunctive pain management therapy is often recognized as an alternative way to reduce opioid 
use postoperatively. Two surgical guidelines suggest clinicians provide adults with acetaminophen in 
conjunction with opioids (American Pain Society’s Clinical Practice Guideline on Management of  
Postoperative Pain, 2016; Enhanced Recovery After Surgery Society’s Guidelines for Care in  
Perioperative Cardiac Surgery, 2019). The combination of opioids and acetaminophen is associated with 
less postoperative pain and/or opioid use compared to opioids alone (American Pain Society, 2016; 
Engelman et al., 2019). Both surgical guidelines previously mentioned also recommend scheduling 
acetaminophen with postoperative CABG patients (American Pain Society, 2016; Engelman et al., 2019). 
Acetaminophen is a vital part of postoperative pain control and reduces opioid consumption by as much 
as 20 percent according to another set of postoperative pain management guidelines published by 
Enhanced Recovery After Surgery Society and European Society of Thoracic Surgeons (2019).   
Utilization of acetaminophen (intravenous and oral) was associated with decreased opioid use 
postoperatively among studies (Looke & Kluth, 2013; MicNicol et al., 2011; Jelacic et al., 2016). Single 
dose acetaminophen was studied for postoperative pain in adults (MicNicol et al., 2016). A systematic 
review (Toms, McQuay, Derry, & Moore, 2008) provided support for acetaminophen serving as effective 
analgesia among 37- 50 percent of patients experiencing acute postoperative pain. Clearly, more studies 
are warranted examining scheduled acetaminophen efficacy among the cardiac surgery patient 
population where more than a single dose of acetaminophen will be administered. Comparative analysis 
of postoperative opioid consumption alongside scheduled oral acetaminophen administration should be 
examined to determine acetaminophen’s association with postoperative opioid use and effects.   
One randomized, placebo-controlled trial claimed a 27 percent decrease in 24-hour 
postoperative opioid use among cardiac surgery patients after scheduled IV acetaminophen for the first 
24 hours (Jelacic et al., 2016). Limitations included a small sample size of 68 participants confined to one 
hospital setting. Conversely, another single-center randomized control trial repeated IV acetaminophen 
administration postoperatively for 24 hours among cardiac surgery patients with a slightly bigger sample 
size of 147 patients to yield no reduction in opioid use among the participants (Mamoun et al., 2016). 
These studies contribute to an increased need for more research involving scheduled postoperative 
acetaminophen IV and PO administration among the cardiac surgery patient population.   
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Methocarbamol is a skeletal muscle relaxant originally developed for musculoskeletal pain 
(Hidalgo & Pusic, 2005). Studies have associated methocarbamol use with diminished postoperative pain 
and opioid consumption (Hidalgo & Pusic, 2005; Looke & Kluth, 2013), however, limited data exists 
examining it’s efficacy among postoperative cardiac surgery patients. Looke & Kluth (2013) examined 
preoperative acetaminophen IV and methocarbamol PO administration on postoperative opioid use 
among total hip and knee replacement surgical patients for 48-hours postoperatively resulting in a 
significant difference in postoperative mean opioid use. The study also suggests a role for 
methocarbamol when muscle spasm is of concern (Looke & Kluth, 2013). One could argue mediastinal 
and intercostal muscle spasms play a role in postoperative cardiac surgery pain while the Society of 
Thoracic Surgeons (2009) claim chest, upper-back and shoulder muscle tightness are common sources of 
cardiac surgery postoperative pain.  Postoperative methocarbamol and acetaminophen were not 
examined among the total hip and knee replacement surgical patient population. Studies involving the 
cardiac surgery patient and methocarbamol administration are warranted.   
To summarize this review of literature, limited research exists among the cardiac surgical patient 
population examining postoperative opioid dependence and associated side effect of nausea. Limited 
evidence exists examining the efficacy of scheduling acetaminophen and methocarbamol  
postoperatively among all surgical patients including the cardiac surgery patient population. Synthesis of 
evidence findings support postoperative opioid use among opioid naïve and tolerant patients as a risk 
for opioid dependence as well as opioid prescriptions at discharge. Few prospective studies exist relating 
cost and consequence of opioid associated side effects among postoperative patients in general, as well 
as in postoperative cardiac surgery patients. Acetaminophen is supported by two postoperative pain 
management guidelines in cardiac surgery while limited studies exist examining methocarbamol 
postoperatively. See appendix two for a full synthesis of evidence table.  
  
DESIGN  
This project involved retrospective chart review comparisons between two cohorts. The first 
cohort, or scheduled cohort, involved scheduling acetaminophen and methocarbamol administration 
postoperatively to cardiac surgery patients and the second cohort involved a non-scheduled control not 
receiving the medications on a scheduled basis. The non-scheduled cohort was still offered the 
medications (acetaminophen and methocarbamol) on an as needed basis. Scheduled was defined as 
receiving acetaminophen and methocarbamol each greater than or equal to four times in 24 hours; 
patients receiving both acetaminophen and methocarbamol greater than or equal to four times in a 
24hour period during their hospital stay were placed into the scheduled cohort. Individuals receiving the 
medications less than four times in a 24 -hour period were assigned to the non-scheduled cohort. Both 
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cohorts were offered standard postoperative opioid therapy. The study involved 77 total patients. The 
scheduled cohort consisted of 27 patients and the non-scheduled cohort consisted of 50 patients. 
Retrospective chart reviews of CABG and valve surgery patients included those admitted to the hospital 
from January 1, 2017- June 1, 2019.   
Data was collected initially from the University of Kentucky’s Center for Clinical and Translational 
Research (CCTS) and validated through electronic health record (EHR) chart reviews conducted by the 
primary investigator and included demographic statistics such as age, gender, procedure type, and 
hospital LOS as well as the following objective one through four.  
  
METHODS  
Study Setting  
The University of Kentucky’s Cardiovascular Intensive Care Unit (CVICU) is where this study’s 
patients were admitted and spent the majority of their hospital stay. The patients were then transferred 
from the CVICU to the associated step-down telemetry floors. The CVICU is comprised of 32 beds and 
more than 30 providers while being known as one of the largest cardiovascular ICU’s in the nation 
offering some of the most innovative technological therapies. These therapies include left/ right 
ventricular assist devices, extracorporeal membrane oxygenation, continuous renal replacement 
therapy, temporary percutaneous ventricular assist devices, intra-aortic balloon pumps, total artificial 
hearts, ultrasound enhanced pulmonary artery thrombolysis, coronary artery bypass grafts, valve 
replacements, coronary artery stents, heart and lung transplants, esophagectomies, pneumonectomies, 
and lobectomies. Nurses in the intensive care unit are staffed to provide care for one or two patients 
depending on acuity. Surgical patients are recovered in the CVICU and then transferred to the service 
line’s acute care floor to prepare for discharge.   
UK Healthcare’s mission is dedicated to the health of the people of Kentucky, striving to provide 
advanced patient care and serving as an information resource (University of Kentucky Albert B. Chandler 
Medical Center, 2019). UK Healthcare also has a strategic plan containing a foundation related to 
patient-centered care. This project aligned with UK Healthcare’s mission and strategic plan because it 
examined ways to reduce patients’ postoperative opioid use in order to reduce opioid-related 
complications. This project is focused on examining potentially harmful opioid related side effects for 
the patient (patient-centered) while also studying the effects of scheduling evidenced-based 
medications (acetaminophen and methocarbamol) postoperatively.  
  
Target Population  
The target population involved cardiac surgery patients specifically coronary artery bypass 
grafts, and valve replacements taking place January 1, 2017- June 1, 2019. Participant inclusion criteria 
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for both cohorts included: males and females, all ages greater than 18 years of age, valve and/or 
coronary artery bypass graft surgery, and all presenting ethnicities. Exclusion criteria for both cohorts 
was non-valve or non-coronary artery bypass graft cardiothoracic surgical patients, patients less than 18 
years of age, patients expiring during their hospital stay, pregnant patients, patients on postoperative 
opioid PCAs or continuous opioid infusions, patients with chronic pain disorders (fibromyalgia, chronic 
back pain), patients with diagnosed opioid use disorder, patients with a hospital length of stay greater 
than 14 days, and patients requiring mechanical circulatory support postoperatively such as 
extracorporeal membrane oxygenation or left/ right ventricular assist devices. Patients were also 
excluded from the study if they only received one or none of the medications (acetaminophen and 
methocarbamol) in the scheduled or non-scheduled cohorts. The two cohorts were divided into two 
cohorts; the scheduled cohort patients received acetaminophen (intravenous and/ or by mouth) and 
methocarbamol greater than or equal to four times in a 24-hour period during their hospital stay. The 
non-scheduled cohort involved patients receiving acetaminophen (intravenous and/ or by mouth) and 
methocarbamol less than four times in a 24-hour period during their hospital stay.    
  
Facilitators and Barriers  
According to Melnyk and Fineout-Overholt (2015), facilitators are individuals carrying out a 
specific role with certain education and skills to ease the transition of applying evidence-based practice. 
Facilitators of this DNP project were the CVICU managers, providers, nurses, pharmacists, university 
statisticians, office of research representatives, and committee members/ clinical mentors- all of whom 
were willing to offer input and guidance to facilitate the success of this study. Barriers of this 
retrospective study included the data collection technological errors from medication counts on all 
charts. The PI was then faced with a time constraint of recounting all medications involved in the 
objectives of this study for every patient to verify an accurate medication count. The PI and CCTS data 
collector also encountered a language barrier involving miscommunication between medical and 
nonmedical backgrounds. This miscommunication was unintentional and required the PI and data 
collector to meet several times to resubmit data collection algorithms for the computerized system to 
collect the data.   
 To complete this study, consistent consultation between multiple disciplines had to occur in 
order to enable creative process development strategies. These consultation methods between CCTS, 
pharmacy, statistician, and committee members involved emails, and in person meetings occurring 
weekly to monthly at various project stages. These strategies created systems that facilitated the data 
collection process on trial and error basis.   
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Procedure   
  UK Institutional Review Board (IRB) exempt approval was obtained for this project on August 26, 
2019 and the study will remain open until August 25, 2025. Informed consent was waived due to the 
minimal risk to the subject (retrospective study), the rights and welfare of subjects were not adversely 
affected, and the research could not have practically been achieved without the requested waiver. A 
waiver of authorization was also obtained. The University of Kentucky Chief of Cardiac Surgery Division, 
Dr. Michael Sekela formally approved this study.   
 Participants’ EHR data was initially collected and deidentified via CCTS and medical record 
numbers were given to the primary investigator (PI) in order to verify the data’s accuracy. The PI verified 
accuracy of all participating patients’ data after receiving it from CCTS. The data was collected, verified, 
and stored on an encrypted, password protected personal laptop.   
  The chart-based data collection for this study included system related issues. The PI met with 
CCTS consultant to categorize data collection identifiers designed to pull data from UK’s patient 
database. The data collection period was from September 2019 to January 2020. Next, the data was 
reevaluated by the PI who verified each variable and cohort assignments for each participant twice in 
the electronic health record before statistical analysis in February 2020. Initially, the study had 577 total 
participants after CCTS’ final data collection. The primary researcher found the following exclusion 
criteria was mistakenly included in the initial data received from CCTS: opioid use disorder, continuous 
opioid PCAs, and those not receiving both scheduled acetaminophen and methocarbamol; these 
patients were excluded. Duplicate MRNs were also discovered especially in patients having both a CABG 
and valve surgery in one procedure, so those patients were also excluded. After these exclusions, a total 
of 77 patients were included. A table of study measures utilized in the data collection process for CCTS is 
included in appendix three.   
  
Data Analysis  
The finalized data was analyzed by the PI and university statistician, Amanda Wiggins. Material 
resources involved in the study included the PI’s already purchased computer, flash drive, IBM SPSS 
software version 24, and printer with paper and ink.   
 Descriptive statistics were utilized in IBM SPSS version 24 to examine percentages of the 
nominal variables of gender, procedure type, discharged on opioids, hospital LOS, and race while the 
continuous variables of age, sum of opiates, sum of nausea medications, and individual counts of 
oxycodone/ hydrocodone/ hydromorphone/ morphine/ promethazine/ ondansetron were analyzed 
descriptively via measures of central tendency and dispersion (mean, median, minimum, maximum, 
standard deviation) for both cohorts. A demographic variable table and objective variable table is 
included in appendices four and five, respectfully.   
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 Comparisons between cohorts (scheduled versus non-scheduled) were conducted using the 
chisquare test of association for nominal variables, or two-sample t-test for continuous measures. An 
alpha level of .05 was used to determine statistical significance.  
  
RESULTS  
A total of 77 patients were included in the retrospective study divided into two cohorts. The 
scheduled cohort had a total of 27 patients, and non-scheduled cohort had a total of 50. The mean age 
for scheduled cohort was 60.8 while non-scheduled was 59.5. Both cohorts had more male participants 
than females; the scheduled cohort (51.9 percent males) and non-scheduled cohort (64 percent males). 
Overall, 97.4 percent (n=75) of all 77 participants identified their race as white. The scheduled cohort 
consisted of 14 CABGs (51.9 percent), 9 valves (33.3 percent), and 4 CABG and valve (14.8%). The 
nonscheduled cohort was comprised of 35 CABGs (70 percent), 13 valves (26 percent), and 2 CABG and 
valve (4 percent). Overall, 51.9 percent (n= 40) of all patients were hospitalized more than one week 
while 48.1 percent (n=37) were less than one week. The variables hospital LOS greater than one week 
and less than one week was analyzed with a chi square test of independence and produced a p value of 
.057 indicating a slight significant difference between the two groups. This indicates an association exists 
between scheduling acetaminophen and methocarbamol and hospital length of stay. A demographic 
variable table is included in appendix four.   
The first objective analyzed resulted in the scheduled cohort having a sum of opioids mean of 
23.5, with a standard deviation of 12.5; the non-scheduled cohort had a sum of opioids mean of 25.5 
with a standard deviation of 10.6. Sum of opioids was defined as total number of occurrences of opioid 
administrations per patient on each patient’s MAR (ex. morphine count + oxycodone count + 
hydrocodone count = sum of opioids). There was no significant difference in means between the two 
cohorts indicating no significant difference between the two cohorts of scheduling (acetaminophen and 
methocarbamol) and postoperative opioid use (p= .47).   
In the second objective, there was no significant difference between the two cohorts (scheduled 
and non- scheduled) of hospital length of stay less than one week and greater than one week and sum of 
opioids (p=.07, .533 respectively); however, less than one week, the p value was substantially lower 
(p=.07) and the mean scores of scheduled less than one week and sum of opioids, n=9 with a mean of 
15.6 (SD 6.1), non-scheduled less than one week n=28 with a mean of 22.1 (SD 9.8). This indicated an 
independent difference between those receiving the scheduled medications (acetaminophen/ 
methocarbamol) and hospital length of stay.   
The third objective statistically studied yielded no significant association (p= .753) between 
discharged on opioids and scheduled versus non- scheduled cohorts.  In the scheduled cohort (n=27), 
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44.4 percent (n=12) were not discharged home on opioids while 48.1 percent were (n=13); however, 7.4 
percent were unknown (n=2). In the non-scheduled cohort (n=50), 36 percent (n=18) were not 
discharged home on opioids, 54 percent were (n=27), and 10 percent were unknown (n=5). 17.4 percent 
collectively were unknown.  
The fourth objective analyzed produced no significant difference between the two cohorts of 
scheduled and non-scheduled (p= .107) and sum of nausea medications. The means of the scheduled 
and non-scheduled cohorts were 3.222 (SD 2.736), and 2.08 (SD 3.04) respectfully, which indicated no 
association between scheduled and non-scheduled cohorts and postoperative antiemetic use. Sum of 
nausea medications was defined as total number of occurrences of ondansetron and promethazine 
administrations on each patient’s MAR (ex. ondansetron count + promethazine count = sum of nausea 
medications).  
An objectives variable table is included in appendix five.  
  
DISCUSSION  
In this retrospective study the effects of scheduling acetaminophen and methocarbamol 
postoperatively to assess outcomes of postoperative opioid use and the associated side effects of 
dependence and nausea were statistically analyzed along with single dose cost analysis of the study’s 
scheduled/ non- scheduled medications. Overall, the study did not produce statistical independence in 
any of the objectives analyzed but when compared to the limited existing research some similarities and 
differences exist. The aims and clinical significance of the study results will be discussed below.  
  Aim One: Does scheduling acetaminophen and methocarbamol postoperatively impact the 
average postoperative opioid use among cohorts?  
   Unfortunately, this study did not see a significant difference in the sum of opioids consumed 
postoperatively between the scheduled and non- scheduled cohorts (p=.470); however, this result does 
not coincide with the postoperative pain management guidelines that claim postoperatively scheduling 
acetaminophen alone can reduce opioid use (American Pain Society, 2016; Engelman et al., 2019). One 
could argue that this study may produce different results should the definition of “scheduling” be 
altered to include more patients in the scheduled cohort. During the data collection process, many 
participants were assigned to the non-scheduled cohort because they missed the 24-hour window of 
receiving methocarbamol and acetaminophen four times in a 24-hour period by minutes to hours. Not 
only might this balance the cohort sample sizes (n= 27 and 50), but also might produce altered mean 
results for opioid use between the two cohorts along with altering all the other measured outcome 
results. Adjustments in the exclusion criteria might also increase the overall sample size which is further 
discussed in the limitations section.  
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  Aim Two: Does scheduling acetaminophen and methocarbamol postoperatively impact the 
average postoperative opioid use among cohorts when examining patients with hospital length of 
stay less than one week and greater than one week?  
When comparing p values of all demographic data collected in this study, a determination was 
made that the variable of hospital LOS (greater than and equal to or less than one week) had the most 
significance (p=.057), see appendix four. This led to a statistical comparison of the sum of opioids with 
respect to hospital LOS greater than and equal to or less than one week for both cohorts (p=.533 and .07 
respectfully). Though this outcome did not produce a statistical difference, one should note the 
individuals in the scheduled cohort staying less than one week had a mean opioid use of 15.6 while 
individuals in the non- scheduled cohort staying less than one week had a mean opioid use of 22.1. This 
could be of use on an individual consumption basis (15 opioid doses during hospital stay is better than 
22) or on an individual cost basis (15 opioids cost less than 22), but also supports the need for more 
research involving postoperative opioid use associated with hospital length of stay especially among the 
cardiac surgery patient to determine statistical difference in a larger, more equal cohort sample size.   
 Aim Three: Does scheduling acetaminophen and methocarbamol postoperatively impact the average 
amount of those discharged home on opioids among cohorts?  
The synthesis of evidence supports that even opioid naïve surgical patients are at risk for 
dependence (Brescia et al., 2019; Sun, Darnell, Baker, & Mackey, 2016; Brummett et al., 2017; Clarke et 
al., 2014; Calcaterra et al., 2015; Mechcatie, 2018) and this study theoretically included all opioid naïve 
patients as patients were excluded with chronic pain disorders like fibromyalgia/ chronic back pain 
(likely prescribed opioids) and patients with diagnosed opioid use disorder. Granted, unknown 
preoperative opioid abuse and prescribed opioid use could be confounding the sample results which 
might also be warranted to consider when developing future research.   
This study did not produce a statistical difference when comparing scheduled and non- 
scheduled cohorts to those discharged home on opioids. One Canadian retrospective cohort study found 
among opioid naïve patients who had major elective surgery including cardiac procedures- 49 percent 
were discharged home with an opioid prescription (Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014). 
When comparing this research to this study’s results, the scheduled cohort had a slightly lower 
percentage of being discharged on opioids (48.1 percent), but when considering the non- scheduled 
cohort’s higher percentage of being discharged on opioids (54 percent) the scheduling may be 
warranted to reduce this hospital region’s average percentage of cardiac surgery patients receiving 
opioids at discharge. Future research is warranted. The alteration of including a 24 hour (+ or – 4 hours) 
for the scheduled cohort, as previously stated, could also produce more significant results among the 
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discharged on opioid percentages between the two cohorts. One should also note 17.4 percent in the 
entire study were not known if they were discharged home on opioids.  
  
  Aim Four: Does scheduling acetaminophen and methocarbamol postoperatively impact the 
average postoperative antiemetic use among cohorts?  
  The literature states nausea is a side effect reported to occur in 25 percent of patients receiving 
opioids. No statistical difference was noted when comparing the sum of nausea medication means to 
the cohorts (p=.107) which supports the first objective’s finding of no significant difference between 
cohorts’ sum of opioid means (23.5= scheduled cohort, 25.5= non-scheduled cohort). Indicating both 
cohorts consumed opioids similarly; therefore, had similar requirements for antiemetics 
postoperatively.  
  
IMPLICATIONS for PRACTICE and FUTURE RESEARCH  
  Literature supports clinical guidelines from the American Pain Society (2016), Enhanced 
Recovery After Surgery Society and European Society of Thoracic Surgeons (2019) for scheduling 
acetaminophen postoperatively to reduce opioid consumption and should be a considered practice 
change for UK’s cardiac surgery patients. Future research is warranted involving the scheduling of 
acetaminophen and methocarbamol postoperatively in cardiac surgery patients as no studies exist 
currently.   
  When developing these future studies, one could argue hospital LOS should be a considered 
factor due to this study’s findings. LOS could be altered related to procedure as CABGs usually have a 
hospital LOS seven days while valves are 14 days at UK Chandler Hospital. LOS could also be altered 
related to common complications that should be considered. Future research is needed for cardiac 
surgery patients and those discharged home on opioids. It would be interesting to see this study’s 
results with an altered “scheduling” definition to include patients receiving acetaminophen and 
methocarbamol greater than or equal to four times in a 24-hour period (+ or – four hours).  
  Another aspect for future research could include a more in-depth consultation with CCTS and 
the data collectors to address ways to mitigate the technological errors encountered with all the 
medication counts on the MARs and other technologically related issues in data collecting. Resolving 
these issues would give the primary investigator more time to address ways to increase reliability and 
validity within the study, and to disseminate future results among the disciplines.  
  In the future, an extensive cost analysis could be valuable in this study to determine which 
combinations of medications (acetaminophen/ methocarbamol or opioids) cost the hospital less.  
Obviously, the study could be strengthened if the acetaminophen/ methocarbamol combination was 
cheaper than opioids; however, if opioids were cheaper one could see why providers would want to 
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abstain from ordering acetaminophen/ methocarbamol due to the additional cost it would present the 
hospital.    
  Dissemination of the surgical guidelines published by the American Pain Society (2016) and The 
Enhanced Recovery After Surgery Society (2019) that promote scheduling acetaminophen 
postoperatively could occur in an educational in-person session to the providers and cardiac surgery 
service line of this study and serve as beneficial along with this study’s clinically relevant findings that 
were previously discussed. A pre and post educational analysis among providers and nurses could be 
included to verify the educational efficacy. This postoperative educational dissemination session could 
also include a compilation of various complementary pain treatment regimens where various methods 
of aromatherapy, acupuncture, massage, music, etc. are presented. If Kolcaba’s Comfort Theory 
Construct of Transcendence is ever attainable, alternative therapies should be discussed in order to 
overcome and rise above opioid dependence and associated side effects.  
  A more involved communicative approach between all disciplines in this study would also serve 
to be beneficial when tackling the technological obstacles encountered within the data collection 
process. This consistent communication could’ve decreased the time to validate data and could’ve also 
prevented technological errors.     
  
LIMITATIONS  
This study was subject to several limitations. The first limitation was overall time. If more time 
were feasible for the data collection process, then the primary investigator could have included a less 
strict “scheduling” definition to involve more patients in the study which would eliminate the limitation 
of small sample size. Instead of the scheduling definition adhering to a strict time frame of receiving the 
scheduled medications greater than or equal to four times in a 24-hour period, a plus or minus fourhour 
window could’ve been used which would’ve included many more patients.   
This small sample size limitation could have also been increased if other exclusion criteria was 
omitted. Many patients were excluded if they had opioid use disorder, fibromyalgia, or chronic back 
pain. Minimal diversity among the patient population was another limitation due to the hospital residing 
in a region where the majority of the population was Caucasian. Selection was not random, as strict 
inclusion and exclusion criteria was used among the cardiac surgery patient population.   
Another limitation was this was a single-center study where multiple doses and routes of the 
medications were used. To increase the reliability of the study, one might suggest a multi-center 
approach where cardiac surgery patients are given the same doses of scheduled, non-scheduled, and 
opioid medications. The last limitation could include that one of the opioid medications examined in 
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both cohorts (hydrocodone) also contained acetaminophen 325 mg and was not counted towards the 
scheduled acetaminophen/ cohort which could threaten internal validity by confounding the results.  
One ethical limitation is that the project author was employed as a registered nurse in the unit 
where the study took place. This means the study’s author could have provided care for the study 
participants which could produce threats to internal validity; however, at the time the care was 
provided, the author would not have known about the patients’ participation because of the 
retrospective nature of the study. The participants were not included until the care had already been 
provided and their discharge completed.   
  
CONCLUSION  
  In conclusion, limited research exists studying postoperative opioid consumption and opioid 
associated effects among cardiac surgical patients when scheduling acetaminophen and 
methocarbamol. This study produced no statistically significant differences among the objectives 
analyzed; however, various clinically significant objectives were discussed. Some of these clinically 
significant objectives involved the consideration of hospital LOS when scheduling acetaminophen and 
methocarbamol postoperatively with respect to reducing postoperative opioid use and scheduling 
acetaminophen and methocarbamol with respect to those being discharged home on opioids. Future 
research is needed regarding contributing factors towards hospital LOS and alternative modalities 
contributing towards hospital LOS. The study supports the need for altering the “scheduled” inclusion 
definition to include a grace period of receiving methocarbamol and acetaminophen greater than or 
equal to four times in 24 hours plus or minus four hours along with less strict exclusion preoperative 
diagnoses criteria. These adjustments in research would increase sample size and potentially produce a 
more reliable study. Literature supports clinical guidelines from the American Pain Society (2016) and 
Enhanced Recovery After Surgery Society (2019) for scheduling acetaminophen postoperatively to 
reduce opioid use and should be a considered practice change for UK’s cardiac surgery patients based on 
findings produced by this study’s review of literature and clinically significant results. In future research, 
hospital LOS and ways to mitigate those discharged home on opioids should be considered as well as a 
more in-depth multidisciplinary communicative approach among the disciplines involved. Limitations to 
this study included time constraints, strict inclusion and exclusion criteria, small sample size with 
minimal diversity, and a single-center study where multiple doses and routes of all the medications 
studied were utilized. This study contributes to the knowledge of the effects related to scheduling 
postoperative acetaminophen and methocarbamol among cardiac surgery patients and has the 
potential to offer insight on future study designs. Should Kolcaba’s Comfort Theory Construct of 
Transcendence ever be attainable, consideration must be made towards alternative postoperative 
therapies such as scheduling acetaminophen and methocarbamol.     
22  
  
 REFERENCES  
  
American Pain Society. (2016). Guidelines on management of postoperative pain. The Journal of Pain, 
17(2), 131-157.  
Brescia, A., Harrington, C., Mazurek, A., Ward, S., Lee, J., Hu, H., . . . Legisetty, K. (2019, February). 
Factors Associated with New Persistant Opioid Usage After Lung Resection. The Annals of 
Thoracic Surgery, 107(2), 363-368.  
Brummett, C., Waljee, J., Goesling, J., Moser, S., Lin, P., Englesbee, M., . . . Nallamothu, B. (2017). New 
Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surgery, 
152(6).  
Calcaterra, S., Yamashita, T., Sung-Joon, M., Keniston, A., Frank, J., & Binswanger, I. (2015, November). 
Opioid prescribing at hospital discharge contributes to chronic opioid use. Journal of General 
Internal Medicine, 31(5), 478-485.  
Clark, D., & Schumacher, M. (2017, November). Anesthesia and Analgesia, 125(5), 1667-1674.  
Clarke, H., Soneji, N., Ko, D., Yun, L., & Wijeysundera, D. (2014, February). Rates and risk factors for 
prolonged opioid use after major surgery: population cohort study. British Medical Journal.  
Compton, P., Mena, G., Sethi, P., & Sigman, S. (2017). United States for Non-Dependence: An Analysis of 
the Impact of Opioid Overprescribing in America. PACIRA Pharmaceuticals Inc.  
Engelman, D., Ali, W., Williams, J., Perrault, L., Reddy, V., Arora, R., . . . Boyle, E. (2019, May 19).  
Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery 
Recommendations. JAMA Surgery, 154(8), 755-766. Retrieved from 
file:///C:/Users/Owner/Downloads/jamasurgery_engelman_2019_sc_190001.pdf  
Enhanced Recovery After Surgery Society and European Society of Thoracic Surgeons. (2019, January). 
Guidlines for Enhanced Recovery after Surgery. European Journal of Cardio-Thoracic Surgery, 
55(1), 91-115.  
Hah, J., Bateman, B., Ratliff, J., Curtin, C., & Sun, E. (2017, November). Chronic opioid use after surgery: 
Implications for perioperative management in the face of the opioid epidemic. International 
Anesthesia Research Society, 125(5), 1733-1740.  
Hidalgo, D., & Pusic, A. (2005, November/ December). The role of methocarbamol and intercostal nerve 
blocks for pain managment in breast augmentation. Aesthetic Surgery Journal, 25, 571-575.  
Hirjii, S., Landino, S., Cote, C., Lee, J., Orhurhu, V. S., McGurk, S., . . . Pelletier, M. (2019). Chronic opioid 
use after coronary bypass surgery. Journal of Cardiac Surgery, 34, 67-73.  
Jelacic, S., Bollag, A., Bowdle, A., Rivat, C., Cain, K., & Richebe, P. (2016 , August). Intravenous  
23  
Acetaminophen as an Adjunct Analgesic in Cardiac Surgery Reduces Opioid Consumption But 
Not Opioid-Related Adverse Effects: A Randomized Control Trial. Journal of Cardiothoracic and 
Vascular Anesthesia, 30(4), 997-1004.  
Kane-Gill, S., Rubin, E., Smithburger, P., Buckley, M., & Dasta, J. (2014, August). The cost of opioid related 
adverse drug events. Journal of Pain and Palliative Care Pharmacotherapy, 28(3), 282293.  
Looke, T., & Kluth, C. (2013, Feburary). Effect of preoperative intravenous methocarbamol and 
intravenous acetaminophen on opioid use after primary total hip and knee replacement.  
Orthopedics, 36, 25-32.  
Mamoun, N., Zimmerman, N., Mascha, E., Mick, S., Insler, S., Sessler, D., & Duncan, A. (2016, 
September). Intravenous acetaminophen analgesia after cardiac surgery: A randomized, 
bilinded, controlled superiority trial. Journal of Thoracic Cardiovascular Surgery, 152(3), 881889.  
McNicol, E., Tzortzopoulou, A., Cepeda, M., Francia, M., Farhat, T., & Schumann, R. (2011, May). 
Singledose intravenous paracetamol or propacetamol for prevention or treatment of 
postoperative pain: a systematic review and meta-analysis. British Journal of Anaesthesia, 
106(6), 784-775.  
Mechcatie, E. (2018, April). Duration of postoperative opioid use predicts misuse more than dosage. 
American Journal of Nursing, 118(4), 15.  
Shah, A., Hayes, C., & Martin, B. (2017, November). Factors influencing long-term opioid use among  
opioid naive patients: an examination of initial prescription characteristics and pain etiologies.  
The Journal of Pain, 18(11), 1374-1383.  
Sun, E., Darnall, B., Baker, L., & Mackey, S. (2016, July). Incidence of and Risk Factors for Chronic Opioid 
Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Internal Medicine, 176(9), 
1286-1293.  
Swegle, J., & Logemann, C. (2006, October 15). Management of common opioid-induced adverse effects.  
American Family Physician, 74(8), 1347-1354.  
Toms, L., McQuay, H., Derry, S., & Moore, R. (2008). Single dose oral paracetamol (acetaminophen) for 
postoperative pain in adults. Cochrane Database Systematic Review.  
University of Kentucky Albert B. Chandler Medical Center. (2019). UK Healthcare Mission and Values.  
Retrieved from UK Healthcare: https://ukhealthcare.uky.edu/about#section-51976  
Urman, R., Seger, D., Fiskio, J., Neville, B., Harry, E., Weiner, S., . . . Schnipper, J. (2019, January). The 
burden of opioid-related adverse drug events on hospitalized previously opioid-free surgical 
patients. Journal of Patient Safety.  
  
  
 
 
24  
  
  
APPENDICES  
  
Appendix One- Kolcaba’s Comfort Theory Conceptual Framework Experienced by Cardiac Surgical 
Patients Through Scheduling Acetaminophen and Methocarbamol   
  
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
Types of Comfort  
E xperienced by  
Cardiac Surgical  
Patients through  
scheduling  
acetaminophen/  
methocarbamol in  
addition to standard  
opioid therapy  
Relief of  
initial pain  
post - op with  
new therapy   
Ease (calm) of new post - op  
pain management therapy  
working to reduce opioid  
related effects of  
dependence and na usea  
while providing adequate  
pain control.   
Transcendence of  patient to  
overcome and rise above  
opioid r elated problems  
( dependence, nausea,) when  
they leave the hospital  
discharge ( ).  
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Appendix Two- Synthesis of Evidence Table  
  
Objectives  
  
  
  
Postoperative 
opioid use  
Postoperative 
opioid 
dependence  
Postoperative 
opioid related 
nausea  
Postoperative  
Scheduling  
Acetaminophen  
Postoperative  
Scheduling  
Methocarbamol  
      
Office of Drug  
Control Policy, 
2018  
X          
Sun et al., 2016  X  X        
Brummet et al., 
2017  
X  X        
Clarke et al., 2014  X  X        
Calceterra et al., 
2015  
X  X        
Mechcatie, 2018  X  X        
Clark & 
Schumacher, 2017  
X  X        
Hirjii et al., 2019    X        
Shah et al., 2017  
  
  X        
Kane-Gill et al.,  
2014  
  
    X      
Swegle &  
Logemann, 2006  
  
    X      
American Pain  
Society, 2016  
  
    X  X    
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Urman et al., 2014  
  
    X      
Engleman et al.,  
2019  
  
X      X    
Looke & Kluth,  
2013  
  
X      X  X  
MicNicol et al., 
2011  
X      X    
Jelacic et al., 2016  
  
X      X    
Toms et al., 2008  X      X    
Mamoun et al., 
2016  
X      X    
Hidalgo & Pusic, 
2005  
X        X  
Enhanced  
Recovery After  
Surgery Society 
and European  
Society of Thoracic  
Surgeons, 2019  
  
X      X    
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Appendix Three-  
TABLE of STUDY MEASURES  
Measures  Description  Level of  
Measurement  
Data Source  
OUTCOMES        
Number of 
occurrences of 
opioid  
administration  
(morphine, 
hydromorphone, 
oxycodone,  
hydrocodone) 
throughout  
hospital stay for 
cohort one and 
two.  
The number of total occurrences 
of received opioids was based on 
the sum of total opioid  
medications being scanned into 
the patients’ medication  
administration records (MARs) 
which is a required nursing  
practice at UK.   
Continuous  
  
  
CCTS provided the data and 
the primary researcher’s  
analyzation of the patients’ 
electronic medical record  
MAR opioid administration 
included the following  
opioids: morphine,  
hydrocodone, oxycodone,  
hydromorphone. Measures of  
central tendency were used to 
compare the mean number of  
the sum of opioid occurrences 
between the two groups via 
SPSS.  
Number of 
occurrences of 
opioid  
administration (as  
above) for cohort 
one and two  
based on length  
of stay (LOS) less 
than one week 
and more than 
one week   
The number of total occurrences 
of received opioids was based on 
the sum of total opioid  
medications being scanned into 
the patients’ MARs for both 
groups which is a required 
practice at UK.  
Continuous  CCTS provided the data and 
the primary researcher’s  
analyzation of the patients’  
MARs opioid administrations 
included the following  
opioids: morphine,  
hydrocodone, oxycodone,  
hydromorphone with respect 
to their hospital LOS.   
Measures of central tendency 
were used to compare the 
mean number of total opioid  
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   occurrences between the two 
cohorts based on a length of 
stay less than one week and 
more than one week via SPSS.  
Nausea via 
documented 
number of  
occurrences of 
antiemetic  
administration  
(ondansetron, 
promethazine) 
throughout  
hospital stay for 
cohort one and 
two.  
The number of total occurrences 
of antiemetic administration  
being scanned into the patients  
MARs . Scanning medication is a 
required nursing practice at UK.   
Continuous  CCTS provided the data and 
the primary researcher’s 
analyzation of patients’  
electronic medical record  
MAR antiemetic 
administration including 
ondansetron and  
promethazine. Measures of  
central tendency were used to 
compare the mean number of 
antiemetic administrations  
between the two cohorts via 
SPSS.    
Cost Analysis  Consultation with UK Healthcare  
Pharmacy Office with the goals 
of obtaining the individual  
hospital purchasing cost of the 
following opioids: morphine,  
hydromorphone, oxycodone,  
and hydrocodone. Another goal 
was to obtain an individual  
hospital purchasing cost of 
acetaminophen and 
methocarbamol.  
Continuous  UK Pharmacy  
Percentage of 
opioid  
prescriptions at  
Discharge medications were 
analyzed for the following 
opioids: oxycodone and  
Nominal   
  
CCTS collected data from the 
patients’ electronic medical 
record for those discharged  
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discharge  
between two 
cohorts  
hydrocodone. Example: yes they 
were discharged on opioids, no 
they were not, or unknown.   
 home on opioids and those  
that were not.  Percentages 
were calculated among the 
two cohorts via SPSS.  
DEMOGRAPHIC  
VARIABLES  
      
Gender  Male vs Female  Nominal   CCTS provided the data and 
the primary researcher   
examined male vs female  
status in patients’ electronic 
medical record  for both  
cohorts. Percentages were 
calculated among the two 
cohorts with analysis in SPSS.  
Age  Mean age in years  Continuous  CCTS provided the data and 
the primary researcher  
examined age in years among  
study participants’ electronic 
medical record in both cohorts 
with analysis in SPSS.  
Procedure Type  CABG, VALVE, CABG and VALVE  Nominal  CCTS provided the data and 
the primary researcher  
examined procedure type  
among study participants’  
electronic medical record in 
both cohorts. Percentages  
were calculated among the 
two cohorts with analysis in 
SPSS.  
Hospital Length of  
Stay (LOS)  
Less than one week vs more than 
one week  
Nominal  CCTS provided the data and 
the primary researcher  
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   examined hospital LOS among  
study participants’ electronic 
medical record for both  
cohorts and percentages were 
calculated with analysis in 
SPSS.  
Race  White vs Non-White  Nominal  CCTS provided the data and 
the primary researcher  
examined race among study  
participants’ electronic health 
record for both cohorts and  
percentages were calculated 
with analysis in SPSS.  
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Appendix Four- Demographic Variable Table  
  Scheduled   
(n =27)  
Mean (SD) or n (%)  
Not scheduled   
(n = 50)  
Mean (SD) or n (%)  
p  
Age  60.81 (9.6)  59.54 (12.1)  .639  
Gender  
   Male  
   Female  
  
14 (51.9%)  
13 (48.1%)  
  
  
32 (64.0%)  
18 (36.0%)  
  
.300  
Procedure type  
   CABG  
   Valve  
   CABG and Valve  
  
14 (51.9%)  
9 (33.3%)  
4 (14.8%)  
  
35 (70.0%)  
13 (26.0%)  
2 (4.0%)  
  
  
.144  
Hospital LOS  
   Less than one week  
   One week or more   
  
9 (33.3%)  
18 (66.7%)  
  
28 (56.0%)  
22 (44.0%)  
  
.057  
Race  
   White  
   Non-white  
  
27 (100%)  
0 (0%)  
  
48 (96%)  
2 (4%)  
  
.292  
  
  
Appendix Five- Objectives Variable Table  
  Objectives  Scheduled   
(n =27)  
Mean (SD) or n (%)  
Not scheduled   
(n = 50)  
Mean (SD) or n (%)  
P  
Objective 1  Sum of Opioids  23.5 (12.5)  25.5 (10.6)  .470  
Objective 2  Sum of Opioids with 
hospital length of stay     
Less than one week     
Greater than one  
week  
  
  
  
n=9, 15.6 (6.1) 
n=18, 27.5 (13.1)  
   
n= 28, 22.1 (9.8) n= 
22, 29.8 (10.2)  
  
  
.070  
.533  
  
Objective 3  Discharged on Opioids  
    Yes  
    No  
    Unknown  
  
13 (48.1%)  
12 (44.4%)  
2 (7.4%)  
  
27 (54%)  
18 (36%)  
5 (10%)  
  
  
.753  
Objective 4  Sum of Nausea 
Medication  
3.22 (2.7)  2.08 (3.0)  .107  
  
  
